Louis Gleckel's Insider Trades & SAST Disclosures
Louis Gleckel's most recent trade in ProPhase Labs Inc was a trade of 100,000 Option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Louis Gleckel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProPhase Labs Inc | Louis Gleckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 100,000 | 100,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Louis Gleckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2024 | 70,000 | 70,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Louis Gleckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 40,000 | 40,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Louis Gleckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 40,000 | 40,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Louis Gleckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 100,000 | 100,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Louis Gleckel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 100,000 | 100,000 | - | - | Option (right to buy) | |
| ProPhase Labs Inc | Louis Gleckel | Director | Purchase of securities on an exchange or from another person at price $ 2.75 per share. | 13 Aug 2020 | 50,000 | 273,840 (2%) | 0% | 2.8 | 137,500 | Common Stock, par value $0.0005 |
| ProPhase Labs Inc | Louis Gleckel | Director | Grant, award, or other acquisition of securities at price $ 1.43 per share. | 01 Jul 2020 | 7,878 | 223,840 (1%) | 0% | 1.4 | 11,266 | Common Stock, par value $0.0005 |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges